Alleviation of severe inflammatory responses in LPS-exposed mice by Schisantherin A

Barnes, 2014, Glucocorticoids, Chem. Immunol. Allergy, 100, 311, 10.1159/000359984 Berkow, 1988, Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor, J. Leukoc. Biol., 44, 345, 10.1002/jlb.44.5.345 Bhatia, 2004, Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome, J. Pathol., 202, 145, 10.1002/path.1491 Bradley, 1982, Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker, J. Investig. Dermatol., 78, 206, 10.1111/1523-1747.ep12506462 Ci, 2010, Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells, Inflammation, 33, 126, 10.1007/s10753-009-9166-7 Cribbs, 2010, Stem cells in sepsis and acute lung injury, Crit. Care Med., 38, 2379, 10.1097/CCM.0b013e3181f96f5f Cuschieri, 2005, Mitogen-activated protein kinase (MAPK), Crit. Care Med., 33, S417, 10.1097/01.CCM.0000191714.39495.A6 El-Agamy, 2011, Nilotinib ameliorates lipopolysaccharide-induced acute lung injury in rats, Toxicol. Appl. Pharmacol., 253, 153, 10.1016/j.taap.2011.03.023 Fulkerson, 1996, Pathogenesis and treatment of the adult respiratory distress syndrome, Arch. Intern. Med., 156, 29, 10.1001/archinte.1996.00440010035006 Goodman, 2003, Cytokine-mediated inflammation in acute lung injury, Cytokine Growth Factor Rev., 14, 523, 10.1016/S1359-6101(03)00059-5 Goss, 2003, Incidence of acute lung injury in the United States, Crit. Care Med., 31, 1607, 10.1097/01.CCM.0000063475.65751.1D Graziano, 1999, Cytokines, chemokines, RANTES, and eotaxin, Allergy Asthma Proc., 20, 141, 10.2500/108854199778553055 Kabir, 2002, Characterization of a murine model of endotoxin-induced acute lung injury, Shock, 17, 300, 10.1097/00024382-200204000-00010 Krawisz, 1984, Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models, Gastroenterology, 87, 1344, 10.1016/0016-5085(84)90202-6 Li, 2014, Tetrahydrocoptisine protects rats from LPS-induced acute lung injury, Inflammation, 10.1007/s10753-014-9945-7 Liu, 2013, Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice, Inflamm. Res., 62, 499, 10.1007/s00011-013-0603-6 Matute-Bello, 2008, Animal models of acute lung injury, Am. J. Physiol. Lung Cell. Mol. Physiol., 295, L379, 10.1152/ajplung.00010.2008 Roth, 2006, Transcription factors in asthma: are transcription factors a new target for asthma therapy?, Curr. Drug Targets, 7, 589, 10.2174/138945006776818638 Sin, 2008, Interleukin-6: a red herring or a real catch in COPD?, Chest, 133, 4, 10.1378/chest.07-2085 Suwa, 2000, Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow, Am. J. Physiol. Heart Circ. Physiol., 279, H2954, 10.1152/ajpheart.2000.279.6.H2954 Tosi, 1992, Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion, Am. J. Respir. Cell Mol. Biol., 7, 214, 10.1165/ajrcmb/7.2.214 Wang, 2011, Resolvin D1 protects mice from LPS-induced acute lung injury, Pulm. Pharmacol. Ther., 24, 434, 10.1016/j.pupt.2011.04.001 Ware, 2000, The acute respiratory distress syndrome, N. Engl. J. Med., 342, 1334, 10.1056/NEJM200005043421806 Xiao, 2012, Curcumin protects against sepsis-induced acute lung injury in rats, J. Surg. Res., 176, e31, 10.1016/j.jss.2011.11.1032 Yen, 2013, Enhancing autophagy with activated protein C and rapamycin protects against sepsis-induced acute lung injury, Surgery, 153, 689, 10.1016/j.surg.2012.11.021 Zhang, 2011, Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice, Eur. J. Pharm. Sci., 44, 573, 10.1016/j.ejps.2011.09.020 Zhang, 2010, Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury, Injury, 41, 746, 10.1016/j.injury.2010.02.029